SOURCE: Kalorama Information
NEW YORK, NY–(Marketwire – December 8, 2010) – Labs using DNA sequencers are more concerned with accuracy than cost in future purchases, according to a survey conducted by Kalorama Information. The healthcare market research publisher reported the survey findings in its recent report, “DNA Sequencing Market Trends (Kalorama Survey of Labs Using Next-Gen and Capillary Systems).”
“A significant number of respondents chose accuracy over cost, ease-of-use or speed,” said Justin Saeks, Kalorama Information’s biotech analyst and author of the report. “This was true both for labs using first-gen or next-gen systems.”
The Kalorama Information survey of 120 laboratories using next-gen and capillary systems was carried out from July to September of 2010, with the majority in the latter portion. About 70% of the labs were academic; the remainders were hospital, government or independent labs. 70% of the hospitals were in North America, 12% in Europe and 18% in ROW. The bulk of respondents were core labs with more than a third doing contract work. Respondents were asked for the most important criteria in considering a new sequencer purchase. Accuracy rated highest for 78.8% of respondents. Cost per sample run was also important, rating second as a criterion with 63.6% of respondents.
Kalorama Information found that the preference for accuracy occurred regardless of whether the survey respondent used a 454, SOLID, Illumina or Capillary System. Saeks, who has been analyzing sequencer markets for the past decade, was not surprised at the ranking of accuracy over other qualities in purchasing new sequencers.
“One of the things we heard from respondents was that accuracy is proportionately more important because in sequencing the margin of error is low,” said Saeks. “Even a .01% error rate adds up to a lot. And accuracy drives other areas — a clean sequence, for instance, will enable software algorithms to work well.”
Kalorama Information has been covering developments in the DNA sequencing markets since 2007. More information on this report, “DNA Sequencing Market Trends (Kalorama Survey of Labs Using Next-Gen and Capillary Systems),” can be found at: http://www.kaloramainformation.com/redirect.asp?progid=80130&productid=2657156.
About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo) and LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g).